ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
Public ClinicalTrials.gov record NCT02817906. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 in the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ITI-007 versus placebo administered orally once daily in the treatment of agitation in patients with dementia, including Alzheimer's disease.
Study identification
- NCT ID
- NCT02817906
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 177 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2016 (Actual)
- Primary completion
- Jan 30, 2019 (Actual)
- Completion
- Jan 30, 2019 (Actual)
- Last update posted
- Jun 29, 2021
2016 – 2019
United States locations
- U.S. sites
- 26
- U.S. states
- 11
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Sun City | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Rogers | Arkansas | — | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | Lemon Grove | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Hallandale | Florida | — | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Suwanee | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Berlin | New Jersey | — | — |
| Not listed | Marlton | New Jersey | — | — |
| Not listed | Toms River | New Jersey | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Centerville | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02817906, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 29, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02817906 live on ClinicalTrials.gov.